文献速递颈动脉与弓上血管

经股动脉颈动脉支架置入术联合近端球囊闭塞脑保护在当代颈动脉狭窄血管内治疗中的作用

The role of transfemoral carotid artery stenting with proximal balloon occlusion embolic protection in the contemporary endovascular management of carotid artery stenosis.
PubMed 文献 · J Vasc Surg · 2020-04-03

该回顾性研究基于SVS VQI数据库2005-2019年24232例颈动脉支架置入患者,比较经股动脉颈动脉支架置入术(tfCAS)联合近端球囊闭塞、tfCAS联合远端脑保护与经颈动脉血运重建术(TCAR)联合血流逆转的院内结局。倾向性匹配后,近端球囊闭塞与远端脑保护在卒中或死亡等主要结局上无差异,但近端球囊闭塞的卒中或死亡风险显著高于TCAR。

要点

  • tfCAS联合近端球囊闭塞与远端脑保护相比,主要结局无显著差异。
  • tfCAS联合近端球囊闭塞的卒中或死亡风险显著高于TCAR联合血流逆转。
  • 近端球囊闭塞未提供与TCAR血流逆转同等程度的脑保护。

核心结论

  • 与tfCAS联合远端脑保护相比,tfCAS联合近端球囊闭塞的主要结局相似。
  • 但与TCAR联合血流逆转相比,tfCAS联合近端球囊闭塞的围手术期卒中或死亡风险显著更高,未提供同等程度的脑保护。

研究设计与样本

  • 回顾性队列研究,使用SVS VQI数据库2005年3月至2019年5月行颈动脉支架置入术的患者。
  • 共24232例手术,其中tfCAS联合近端球囊闭塞561例(2.3%),tfCAS联合远端脑保护18126例(74%),TCAR联合血流逆转5545例(22.9%)。
  • 采用倾向性评分匹配,以tfCAS联合近端球囊闭塞为比较队列,评估院内结局。

临床怎么用

  • 在颈动脉狭窄血管内治疗中选择脑保护方式时,tfCAS联合近端球囊闭塞可作为远端脑保护的替代,但需知晓其脑保护效果不及TCAR联合血流逆转。
  • 对于卒中高风险患者,优先考虑TCAR联合血流逆转可能更有利于降低围手术期卒中或死亡风险。

局限性

  • 回顾性研究设计,存在选择偏倚和未测量混杂因素可能。
  • 仅评估院内结局,缺乏长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent data have shown that transcarotid artery revascularization (TCAR) with flow reversal provides a superior method of embolic protection compared with transfemoral carotid artery stenting (tfCAS) with distal embolic protection. Flow reversal or flow arrest systems with proximal endovascular balloon occlusion can also be used through the transfemoral approach; however, their outcomes compared with TCAR with flow reversal and tfCAS with distal embolic protection are poorly described. METHODS: We performed a retrospective review of all patients undergoing tfCAS with proximal balloon occlusion, tfCAS with distal embolic protection, and TCAR with flow reversal in the Society for Vascular Surgery Vascular Quality Initiative from March 2005 to May 2019. We assessed in-hospital outcomes in propensity score-matched cohorts of patients using tfCAS with proximal balloon occlusion as the comparison cohort. The primary outcome was stroke or death. Secondary end points included the individual outcomes of stroke, death, transient ischemic attack (TIA), and myocardial infarction. RESULTS: Of the 24,232 patients undergoing carotid artery stenting, 561 (2.3%) procedures were performed through tfCAS with proximal balloon occlusion, 18,126 (74%) through tfCAS with distal embolic protection, and 5545 (22.9%) through TCAR with flow reversal. After matching, 463 pairs of patients undergoing tfCAS with proximal balloon occlusion and tfCAS with distal embolic protection were identified. There were no differences in stroke or death (proximal balloon, 3.2%; distal embolic protection, 3.7%; relative risk [RR], 0.88; 95% confidence interval [CI], 0.45-1.73; P = .73), stroke (2.4% vs 2.6%; RR, 0.92; 95% CI, 0.42-2.00; P = .83), death (1.1% vs 1.5%; RR, 0.71; 95% CI, 0.41-3.15; P = .80), TIA (1.7% vs 1.5%; RR, 1.14; 95% CI, 0.41-3.15; P = .80), or myocardial infarction (0.4% vs 0.6%; RR, 0.67; 95% CI, 0.11-3.99; P = .65). However, after matching 357 pairs of patients undergoing tfCAS with proximal balloon occlusion and TCAR with flow reversal, tfCAS with proximal balloon occlusion was associated with higher rates of stroke or death (3.1% vs 0.8%; RR, 3.67; 95% CI, 1.02-13.14; P = .03) and a trend toward higher rates of stroke (2.5% vs 0.8%; RR, 3.00; 95% CI, 0.81-11.08; P = .08) and death (0.8% vs 0.0%; P = .08), but no statistically significant differences in TIA (0.8% vs 0.8%; P > .99) or myocardial infarction (0.6% vs 0.3%; RR, 2.00; 95% CI, 0.18-22.06; P = .56). CONCLUSIONS: Compared with tfCAS with distal embolic protection, tfCAS with proximal balloon occlusion has similar major outcomes. However, tfCAS with proximal balloon occlusion does not offer the same degree of embolic protection compared with TCAR with flow reversal, given the significantly higher risk of perioperative stroke or death.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Liang P, Soden P, Wyers MC, et al. The role of transfemoral carotid artery stenting with proximal balloon occlusion embolic protection in the contemporary endovascular management of carotid artery stenosis. J Vasc Surg. 2020. PMID: 32251772. doi:10.1016/j.jvs.2020.02.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。